Please ensure Javascript is enabled for purposes of website accessibility

3 Ways That Canopy Growth Beats Tilray

By Keith Speights – Aug 12, 2021 at 5:55AM

Key Points

  • Although Tilray expected to be No. 1 in the Canadian recreational-marijuana market after its merger with Aphria, Canopy Growth still holds the top spot.
  • Canopy's cash stockpile is much larger than Tilray's.
  • Both companies have U.S. operations, but Canopy is in a stronger position to expand into the U.S. cannabis market when federal laws permit.

Motley Fool Issues Rare “All In” Buy Alert

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

All of them are more important than market cap -- another front where Canopy tops Tilray.

There are two top players in the Canadian cannabis market. And then there's the rest of the pack. Canopy Growth (CGC 4.57%) has reigned throughout much of the last few years as the biggest Canadian cannabis producer based on market cap. But thanks to its merger with Aphria earlier this year, Tilray (TLRY 1.85%) now runs neck and neck with Canopy.

Tilray has also been the much bigger winner this year in terms of stock performance. Its shares have skyrocketed more than 70%. Meanwhile, Canopy Growth stock has floundered, falling more than 20% year to date. 

Don't think that Canopy will necessarily play second fiddle to Tilray going forward, though. Here are three key ways that Canopy Growth beats Tilray.

Cannabis growing in a greenhouse.

Image source: Getty Images.

1. Canadian recreational market share

When Aphria and Tilray announced plans to merge back in December 2020, the companies claimed that they would together have the largest market share in the Canadian recreational adult-use cannabis market. However, the Aphria-Tilray merger closed in May, yet the combined entity doesn't rank No. 1 in said market. 

In Canopy Growth's fiscal 2022 Q1 conference call last week, CEO David Klein stated, "Amid a very competitive environment, we maintained market share leadership with 15.2% share of the tracked provinces in Q1 2021." Canopy held that top spot, thanks to its own acquisitions of Ace Valley and Supreme Cannabis.

Tilray is the biggest moneymaker in the total Canadian cannabis market, including medical and recreational sales. It has also been gaining overall market share each month since April. For now, though, there's one top dog in the Canadian recreational market -- and it's Canopy Growth, not Tilray.

2. Cash

If cash is king, then Canopy Growth definitely sits on the cannabis throne. The company's cash and short-term investments totaled 2.1 billion in Canadian dollars (close to $1.7 billion) as of June 30, 2021.

Tilray's cash stockpile doesn't come close to that that level. The company reported cash and cash equivalents of $488.5 million as of May 31, 2021.

Neither one of these cannabis operators is generating real positive earnings right now. The profits that both Canopy Growth and Tilray posted in their latest quarters were due to changes in the fair value of derivative liabilities. Basically, both marijuana stocks fell, which gave them other income on paper related to a change in the value of warrants for Canopy and convertible debentures for Tilray.

Because they're not truly profitable, both Canopy and Tilray need cash for operations and for any expansion plans. Canopy is clearly in the stronger position on this front.

3. U.S. positioning

The last way that Canopy Growth beats Tilray is arguably the most important. Both of these companies anxiously await the opportunity to enter the U.S. cannabis market. Canopy is in a better position to do so than its competitor.

Tilray already operates in the U.S. The company owns hemp-foods maker Manitoba Harvest and craft-beer maker SweetWater Brewing. However, these operations aren't on par with Canopy Growth's U.S. positioning.

Canopy has a growing CBD business in the U.S. Its Martha Stewart CBD brand now ranks No. 3 in the U.S., and Canopy's Quatreau CBD-infused beverages have been launched in seven states so far.

The company has a big U.S. partner (and largest shareholder) in adult-beverage giant Constellation Brands. It also owns an option to acquire U.S. cannabis operator Acreage Holdings and a significant stake in Terrascend, pending federal cannabis reform.

Tilray's Simon said in the company's latest quarterly update that Tilray will pursue mergers or acquisitions of U.S. multistate operators when cannabis is legalized in the U.S. That makes sense. However, Canopy is already set and ready to go now, while Tilray is waiting.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Constellation Brands. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Canopy Growth Corp. Stock Quote
Canopy Growth Corp.
CGC
$3.66 (4.57%) $0.16
Constellation Brands Stock Quote
Constellation Brands
STZ
$257.49 (0.31%) $0.80
Acreage Holdings, Inc. Stock Quote
Acreage Holdings, Inc.
ACRGF
TerrAscend Corp. Stock Quote
TerrAscend Corp.
TRSSF
$1.85 (3.93%) $0.07
Tilray, Inc. Stock Quote
Tilray, Inc.
TLRY
$3.85 (1.85%) $0.07

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
356%
 
S&P 500 Returns
118%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.